한글목차

세계의 열사병 치료제 시장은 병원, 진료소, 재택 케어 시장의 기회에 의해 장래가 유망시되고 있습니다. 열사병 치료제 시장은 2025-2031년 CAGR은 13.1%를 보일 전망입니다. 이 시장의 주요 촉진 요인은 열사병 발생률 증가로 효과적인 치료 수요가 촉진되고, 열 관련 질환에 대한 인식과 대비 태세 강화가 시장 성장을 부추기고 있습니다.

• Lucintel사의 예측에서는 유형별로는 주사약이 예측 기간 중에 높은 성장을 이룰 전망입니다.
• 용도별로는 병원이 가장 높은 성장이 예상됩니다.
• 지역별로는 아시아태평양이 예측 기간 동안 가장 높은 성장이 예상됩니다.

열사병 치료제 시장의 새로운 동향

열사병 치료제 시장은 기술 혁신, 열 관련 건강 위험에 대한 인식 제고, 정부 개입 확대 등 여러 주요 동향과 함께 진화하고 있습니다. 이러한 동향은 시장을 재편하면서 이해관계자들에게 새로운 기회를 제공하고 도전 과제를 제시하고 있습니다.

• 기술 혁신 : 스마트 조끼 및 패치와 같은 웨어러블 냉각 장치의 발전은 열사병 예방을 향상시키고 있습니다. 이러한 기기들은 상변화 물질이나 냉각 메커니즘 같은 기술을 활용해 체온을 감축합니다. 이 동향은 의약품 외에 확대되며, 기존 열사병 치료법에 대한 보완적 접근법을 제공합니다.
• 인식 제고 : 특히 극한 기상 조건 시 열사병 위험에 대한 공공 교육 및 인식 캠페인이 더욱 보편화되고 있습니다. 이로 인해 개인과 기관의 보호용 의약품 및 냉각 솔루션 채택이 증가하여 시장 접근성이 확대되고 신제품 출시 기회가 창출되고 있습니다.
• 정부 뒷받침 : 전 세계 정부는 극심한 더위의 건강 위험을 인식하여 열사병 예방 프로그램에 대한 규제 강화 및 자금 지원을 확대하고 있습니다. 이러한 지원은 열 관련 의약품 및 기술 혁신을 촉진하여 열사병 퇴치를 위한 보다 적극적인 접근 방식을 조성하고 있습니다.
• 스포츠 의료의 부상 : 야외 스포츠 참여 증가가 운동선수를 위한 열사병 치료제 수요를 촉진하고 있습니다. 특별히 제조된 전해질 보충제, 수분 보충 정제, 냉각 젤이 운동선수들 사이에서 인기를 얻으며 시장 성장에 기여하고 있습니다. 이러한 동향은 특정 소비자 요구를 겨냥한 더 전문화된 제품 개발을 촉진하고 있습니다.
• 기후 변화 적응 : 기후 변화로 인해 극심한 더위 현상이 빈번해지면서 전 세계적으로 열사병 예방 의약품에 대한 수요가 촉진되고 있습니다. 제약 업계는 특히 장기간 열파가 발생하는 지역에 맞춰 오래 지속되는 보호 효과를 제공하는 새로운 제형을 개발하며 대응하고 있습니다. 이러한 적응은 시장 역학을 재편하고 열사병 솔루션에 대한 투자를 촉진하고 있습니다.

이러한 신흥 동향은 열사병 예방 의약품 시장을 재편하며, 열 관련 질환 예방 및 치료에 있어 기술적 발전, 공공의 인식, 정부 개입의 중요성을 부각시키고 있습니다. 이러한 동향이 계속 진화함에 따라 해당 시장의 전망을 정의할 가능성이 높으며, 기업에 상당한 성장 기회를 제공하고 전 세계 보건 회복탄력성을 향상시킬 것입니다.

열사병 치료제 시장의 최근 동향

열사병 예방 의약품 시장의 최근 동향은 전 세계 온난화, 극심한 폭염 및 이들이 공공 보건에 미치는 영향에 대한 우려 증가를 반영합니다. 취약 계층과 고위험 환경에 특히 주목하면서, 의약품, 예방 제품 및 정부 정책의 발전이 이 확대되는 시장을 형성하고 있습니다.

• 의약품 혁신 : 열사병에 더 효과적으로 대처하기 위해 재수화제 및 전해질 보충 용액을 포함한 새로운 의약품이 도입되었습니다. 이러한 약물은 더 빠른 회복과 열이 신체에 미치는 영향 감축에 도움을 주어 극심한 더위를 겪는 지역에서 상당한 수요를 창출하고 있습니다.
• 냉각 기술 통합 : 냉각 기술을 열사병 예방 제품에 통합함으로써 냉각 조끼, 바디 랩, 웨어러블 냉각 장치와 같은 혁신이 이루어졌습니다. 이러한 제품들은 야외 활동이 많은 시장에서 주목받고 있으며, 비침습적이고 즉각적인 열사병 예방 방법을 제공합니다.
• 정부 조치 : 여러 국가 정부가 열사병 예방 프로그램 및 규제에 대한 투자를 확대하고 있습니다. 냉각 스테이션, 보호 장비, 비상 대응 계획의 보급을 촉진하는 이니셔티브는 열사병 관리에 보다 적극적인 접근 방식을 마련하는 데 기여했습니다.
• 공공 보건 캠페인 : 기후 변화에 주력함에 따라 국가들은 열사병 증상과 예방에 대한 인식을 제고하기 위한 공공 교육에 투자하고 있습니다. 이러한 캠페인은 보호 제품의 광범위한 채택으로 이어져 열사병 예방 의약품 시장을 활성화하고 있습니다.
• 취약 계층을 주력합니다 : 열사병 관련 질환에 더 취약한 노인 및 취약 계층을 대상으로 한 열사병 예방 의약품 개발이 증가하고 있습니다. 열사병 예방 의약품 및 냉각 장치 등 이들을 대상으로 한 특수 제품이 급속히 성장하고 있습니다.

이러한 발전은 열사병이라는 전 세계 과제를 해결하는 데 기술과 공공 정책의 역할이 확대되고 있음을 보여줍니다. 혁신이 지속적으로 등장하고 의료 시스템이 극심한 더위의 증가하는 위험에 적응함에 따라, 전 세계 열사병 치료제 시장은 지속적인 성장을 준비하고 있습니다.

목차

제1장 주요 요약

제2장 시장 개요

• 배경과 분류
• 공급망

제3장 시장 동향과 예측 분석

• 업계의 촉진요인과 과제
• PESTLE 분석
• 특허 분석
• 규제 환경

제4장 세계의 열사병 치료제 시장 : 유형별

• 개요
• 유형별 : 매력 분석
• 경구약 : 동향과 예측(2019-2031년)
• 주사약 : 동향과 예측(2019-2031년)
• 기타 : 동향과 예측(2019-2031년)

제5장 세계의 열사병 치료제 시장 : 용도별

• 개요
• 용도별 : 매력 분석
• 병원 : 동향과 예측(2019-2031년)
• 클리닉 : 동향과 예측(2019-2031년)
• 재택 케어 : 동향과 예측(2019-2031년)
• 기타 : 동향과 예측(2019-2031년)

제6장 지역 분석

• 개요
• 지역별 : 세계의 열사병 치료제 시장

제7장 북미의 열사병 치료제 시장

• 개요
• 북미의 열사병 치료제 시장(유형별)
• 북미의 열사병 치료제 시장(용도별)
• 미국의 열사병 치료제 시장
• 멕시코의 열사병 치료제 시장
• 캐나다의 열사병 치료제 시장

제8장 유럽의 열사병 치료제 시장

• 개요
• 유럽의 열사병 치료제 시장(유형별)
• 유럽의 열사병 치료제 시장(용도별)
• 독일의 열사병 치료제 시장
• 프랑스의 열사병 치료제 시장
• 스페인의 열사병 치료제 시장
• 이탈리아의 열사병 치료제 시장
• 영국의 열사병 치료제 시장

제9장 아시아태평양의 열사병 치료제 시장

• 개요
• 아시아태평양의 열사병 치료제 시장(유형별)
• 아시아태평양의 열사병 치료제 시장(용도별)
• 일본의 열사병 치료제 시장
• 인도의 열사병 치료제 시장
• 중국의 열사병 치료제 시장
• 한국의 열사병 치료제 시장
• 인도네시아의 열사병 치료제 시장

제10장 기타 지역의 열사병 치료제 시장

• 개요
• 기타 지역의 열사병 치료제 시장(유형별)
• 기타 지역의 열사병 치료제 시장(용도별)
• 중동의 열사병 치료제 시장
• 남미의 열사병 치료제 시장
• 아프리카의 열사병 치료제 시장

제11장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석
  • 경쟁 기업간 경쟁 관계
  • 구매자의 협상력
  • 공급기업의 협상력
  • 대체품의 위협
  • 신규 참가업체의 위협
• 시장 점유율 분석

제12장 기회와 전략 분석

• 밸류체인 분석
• 성장 기회 분석
  • 유형별 성장 기회
  • 용도별 성장 기회
• 세계의 열사병 치료제 시장의 새로운 동향
• 전략 분석
  • 신제품 개발
  • 인증 및 라이선싱
  • 합병, 인수, 계약, 제휴, 합작 사업

제13장 밸류체인 전체에 걸친 주요 기업의 기업 프로파일

• Competitive Analysis
• Pfizer
• GlaxoSmithKline
• Novartis AG
• Sanofi SA
• Johnson & Johnson

제14장 부록

• 도표 일람
• 표 목록
• 조사 방법
• 면책사항
• 저작권
• 약어와 기술 단위
• 당사에 대해
• 문의

영문목차

The future of the global anti-heat stroke medicine market looks promising with opportunities in the hospitals, clinics, and homecare markets. The global anti-heat stroke medicine market is expected to grow with a CAGR of 13.1% from 2025 to 2031. The major drivers for this market are the increasing incidences of heat stroke drive demand for effective treatments and the rising awareness and preparedness for heat-related illnesses boost market growth.

• Lucintel forecasts that, within the type category, injectable medication is expected to witness higher growth over the forecast period.
• Within the application category, hospitals is expected to witness the highest growth.
• In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Anti-Heat Stroke Medicine Market

The anti-heat stroke medicine market is evolving with several key trends, including technological innovations, increasing awareness of heat-related health risks, and growing government intervention. These trends are reshaping the market, offering new opportunities and presenting challenges for stakeholders.

• Technological Innovations: Advancements in wearable cooling devices, such as smart vests and patches, are enhancing heat stroke prevention. These devices use technologies like phase-change materials or cooling mechanisms to reduce body temperature. This trend is expanding beyond pharmaceuticals, offering a complementary approach to traditional heat stroke treatments.
• Increased Awareness: Public education and awareness campaigns about heat stroke risks, especially during extreme weather conditions, are becoming more common. This has led to greater adoption of protective medications and cooling solutions by individuals and organizations, expanding market reach and creating opportunities for new product offerings.
• Government Support: Governments around the world are recognizing the health risks of extreme heat, resulting in stronger regulation and funding for heatstroke prevention programs. This support is fueling innovation in heat-related medications and technologies, fostering a more proactive approach to combatting heatstroke.
• Rise in Sports Medicine: The growing participation in outdoor sports has driven demand for heat stroke treatments designed for athletes. Specially formulated electrolyte supplements, rehydration tablets, and cooling gels are gaining popularity among athletes, contributing to market growth. This trend is pushing for more specialized products targeting specific consumer needs.
• Climate Change Adaptation: Climate change has led to increased frequency of extreme heat events, driving the global need for anti-heat stroke medicines. The pharmaceutical industry is responding by developing new formulations that provide long-lasting protection, specifically for regions prone to prolonged heatwaves. This adaptation is reshaping market dynamics and driving investment in heatstroke solutions.

These emerging trends are reshaping the anti-heat stroke medicine market, highlighting the importance of technological advances, public awareness, and government involvement in preventing and treating heat-related illnesses. As these trends continue to evolve, they will likely define the future of this sector, providing significant growth opportunities for companies and improving global health resilience to extreme heat.

Recent Developments in the Anti-Heat Stroke Medicine Market

Recent developments in the anti-heat stroke medicine market reflect growing concerns over global warming, extreme heat waves, and their impacts on public health. Advancements in pharmaceuticals, preventive products, and governmental policies are shaping this expanding market, with particular attention given to vulnerable populations and high-risk environments.

• Pharmaceutical Innovation: New medications, including rehydration formulas and electrolyte replacement solutions, have been introduced to better combat heatstroke. These medications help in faster recovery and reducing the impact of heat on the body, creating significant demand in regions facing extreme heat.
• Cooling Technology Integration: The integration of cooling technologies into heatstroke prevention products has led to innovations such as cooling vests, body wraps, and wearable cooling devices. These products are gaining traction in markets with high outdoor activity, offering a non-invasive and immediate way to prevent heat stroke.
• Government Action: Various governments are increasing investments in heatstroke prevention programs and regulations. Initiatives to promote the availability of cooling stations, protective gear, and emergency response plans have contributed to a more proactive approach to heatstroke management.
• Public Health Campaigns: With more focus on climate change, countries are investing in public education to raise awareness of heat stroke symptoms and prevention. These campaigns are leading to wider adoption of protective products, boosting the market for anti-heat stroke medicines.
• Focus on Vulnerable Populations: Anti-heat stroke medicine developments are increasingly focused on elderly and vulnerable groups, who are more susceptible to heat-related illnesses. Specialized products targeting these populations, such as heat-stroke-preventing medications and cooling devices, are seeing rapid growth.

These developments highlight the expanding role of both technology and public policy in addressing the global challenge of heat stroke. As innovations continue to emerge and healthcare systems adapt to the rising risks of extreme heat, the global anti-heat stroke medicine market is poised for sustained growth.

Strategic Growth Opportunities in the Anti-Heat Stroke Medicine Market

The global anti-heat stroke medicine market is evolving with several strategic growth opportunities, especially in the areas of product development, healthcare infrastructure, and public health initiatives. These opportunities represent a growing demand for new solutions in preventing and treating heat stroke across various sectors.

• Preventative Products: As awareness of heatstroke risks grows, demand for preventative products like hydration supplements, cooling garments, and heat-relief gels is increasing. These products are seeing significant interest in sectors like sports and outdoor recreation, driving further product innovation.
• Elderly Care Solutions: With aging populations worldwide, there is an increasing need for heat stroke treatments specifically designed for elderly individuals. Specialized medications and cooling technologies targeting older adults are seeing growth, as this demographic is highly susceptible to heat-related health issues.
• Sports and Outdoor Recreation: The rise of outdoor sports and recreational activities is driving demand for heat stroke prevention products tailored for athletes. Innovative solutions like electrolyte-enhanced beverages, cooling vests, and rehydration tablets are in high demand.
• Telemedicine Integration: The rise of telemedicine and digital health tools presents opportunities for remote diagnosis and treatment of heatstroke. Companies are exploring digital platforms that can assist with heatstroke monitoring and provide access to preventive medications, thus expanding the market.
• Government Collaboration: Strategic partnerships between pharmaceutical companies and governments to combat heatstroke risks through public health campaigns and emergency programs are creating significant opportunities. These collaborations support large-scale distribution of preventive medicines and educational materials.

These growth opportunities highlight the dynamic nature of the anti-heat stroke medicine market, where innovation and public health efforts are driving change. By focusing on vulnerable populations, leveraging technological advancements, and collaborating with governments, businesses can tap into these opportunities for growth and contribute to global heat stroke prevention.

Anti-Heat Stroke Medicine Market Driver and Challenges

The anti-heat stroke medicine market is influenced by various technological, economic, and regulatory drivers and challenges. These factors shape market growth, opportunities, and the development of effective solutions for heat stroke prevention and treatment.

The factors responsible for driving the anti-heat stroke medicine market include:

1. Increasing Temperatures and Extreme Heat Events: The rise in global temperatures, exacerbated by climate change, has led to more frequent heatwaves. This has directly driven the demand for anti-heat stroke products, as both individuals and organizations seek ways to mitigate the impact of extreme heat.

2. Rising Awareness of Heat Stroke Risks: Growing public awareness about the dangers of heatstroke, particularly during extreme weather conditions, has led to greater consumer interest in preventive products and treatments. As more people become educated, the demand for effective heatstroke remedies has increased.

3. Technological Advancements: Innovations in cooling technologies, such as wearable devices and smart fabrics, are providing new ways to prevent and treat heat stroke. These technological advances are driving market growth by offering practical, non-invasive solutions to combat heat-related illnesses.

4. Government Initiatives and Funding: Governments across the world are allocating more resources to combat heat-related illnesses, including funding for public health campaigns, heat relief centers, and research into new treatments. These initiatives are boosting market growth.

5. Growing Outdoor Sports Participation: As more people engage in outdoor sports, particularly in regions with hot climates, the demand for heat stroke prevention products tailored to athletes is rising. Specialized treatments and products are becoming essential for those participating in high-risk activities.

Challenges in the anti-heat stroke medicine market are:

1. High Cost of Advanced Solutions: The development and implementation of advanced cooling technologies and medications can be expensive. The high cost of these solutions may limit their accessibility in low-income regions, challenging the broader adoption of heat stroke prevention products.

2. Regulatory Barriers: While the demand for anti-heat stroke medicines grows, regulatory barriers can slow product approval processes. Governments need to establish clear guidelines for the efficacy and safety of new products, which can delay their entry into the market.

3. Seasonal Demand Fluctuations: The demand for anti-heat stroke medicines often spikes during hot weather periods, creating seasonal fluctuations. Manufacturers must manage production to address this demand without incurring excess inventory costs during cooler months.

The anti-heat stroke medicine market is shaped by both significant drivers, such as climate change and technological innovations, and substantial challenges, such as high costs and regulatory hurdles. Addressing these factors will be critical for stakeholders to fully capitalize on the market's growth potential and improve the global response to heat-related illnesses.

List of Anti-Heat Stroke Medicine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies anti-heat stroke medicine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the anti-heat stroke medicine companies profiled in this report include-

• Pfizer
• GlaxoSmithKline
• Novartis AG
• Sanofi S.A.
• Johnson & Johnson

Anti-Heat Stroke Medicine Market by Segment

The study includes a forecast for the global anti-heat stroke medicine market by type, application, and region.

Anti-Heat Stroke Medicine Market by Type [Value from 2019 to 2031]:

• Oral Medication
• Injectable Medication
• Others

Anti-Heat Stroke Medicine Market by Application [Value from 2019 to 2031]:

• Hospitals
• Clinics
• Homecare
• Others

Anti-Heat Stroke Medicine Market by Region [Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Anti-Heat Stroke Medicine Market

The global anti-heat stroke medicine market has seen significant growth, driven by the increasing frequency and intensity of heatwaves worldwide. As countries like the U.S., China, Germany, India, and Japan face rising temperatures, the need for effective preventive and treatment solutions for heat-related illnesses has intensified. This demand has led to notable developments in research, product availability, and regulatory frameworks in the anti-heat stroke sector.

• United States: In the U.S., the anti-heat stroke medicine market has witnessed advancements in both pharmaceutical and preventive products. The increasing awareness of heatstroke risks, especially in sports and outdoor activities, has prompted greater investment in over-the-counter (OTC) and prescription-based treatments. The market has also benefited from innovative heat management solutions, such as cooling vests and electrolyte-replenishing medications, being integrated into sports and outdoor safety protocols.
• China: China's market for anti-heat stroke medicines is growing rapidly due to climate change and urbanization, which has resulted in more people exposed to high temperatures. Traditional medicine and modern pharmaceuticals are both being utilized to combat heat stroke, with growing research on natural remedies alongside synthetic drugs. The Chinese government has also increased its focus on public health campaigns aimed at preventing heat-related illnesses, which further drives the demand for heat stroke medications.
• Germany: Germany has focused on developing preventative medicine for heat stroke, particularly for vulnerable groups such as the elderly. With the rise of extreme weather conditions in Europe, Germany has seen significant efforts from the healthcare sector to improve access to effective medications and cooling solutions. The government has also pushed for better climate resilience in healthcare infrastructure, leading to more research into heatstroke prevention and treatment methods for public health improvement.
• India: India faces an urgent need for anti-heat stroke solutions due to extreme summer temperatures. Both local and global pharmaceutical companies are increasingly investing in products designed to alleviate heatstroke symptoms and prevent heat-related health issues. Moreover, India's government is focusing on public health initiatives, especially in rural and underserved areas, to reduce the impact of extreme heat and prevent heatstroke fatalities, driving growth in the anti-heat stroke medicine sector.
• Japan: Japan has long been a pioneer in addressing the risks of heat stroke, especially during the hot summer months. The Japanese market has seen innovations in both preventative and therapeutic products, including cooling beverages and heatstroke-preventing drugs. Additionally, Japan's aging population has increased demand for effective treatments targeted at older individuals who are more vulnerable to heatstroke. Technological innovations in wearable cooling devices have also contributed to market expansion.

Features of the Global Anti-Heat Stroke Medicine Market

• Market Size Estimates: Anti-heat stroke medicine market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
• Segmentation Analysis: Anti-heat stroke medicine market size by type, application, and region in terms of value ($B).
• Regional Analysis: Anti-heat stroke medicine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the anti-heat stroke medicine market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the anti-heat stroke medicine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the anti-heat stroke medicine market by type (oral medication, injectable medication, and others), application (hospitals, clinics, homecare, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global Anti-Heat Stroke Medicine Market by Type

• 4.1 Overview
• 4.2 Attractiveness Analysis by Type
• 4.3 Oral Medication: Trends and Forecast (2019-2031)
• 4.4 Injectable Medication: Trends and Forecast (2019-2031)
• 4.5 Others: Trends and Forecast (2019-2031)

5. Global Anti-Heat Stroke Medicine Market by Application

• 5.1 Overview
• 5.2 Attractiveness Analysis by Application
• 5.3 Hospitals: Trends and Forecast (2019-2031)
• 5.4 Clinics: Trends and Forecast (2019-2031)
• 5.5 Homecare: Trends and Forecast (2019-2031)
• 5.6 Others: Trends and Forecast (2019-2031)

6. Regional Analysis

• 6.1 Overview
• 6.2 Global Anti-Heat Stroke Medicine Market by Region

7. North American Anti-Heat Stroke Medicine Market

• 7.1 Overview
• 7.2 North American Anti-Heat Stroke Medicine Market by type
• 7.3 North American Anti-Heat Stroke Medicine Market by application
• 7.4 United States Anti-Heat Stroke Medicine Market
• 7.5 Mexican Anti-Heat Stroke Medicine Market
• 7.6 Canadian Anti-Heat Stroke Medicine Market

8. European Anti-Heat Stroke Medicine Market

• 8.1 Overview
• 8.2 European Anti-Heat Stroke Medicine Market by type
• 8.3 European Anti-Heat Stroke Medicine Market by application
• 8.4 German Anti-Heat Stroke Medicine Market
• 8.5 French Anti-Heat Stroke Medicine Market
• 8.6 Spanish Anti-Heat Stroke Medicine Market
• 8.7 Italian Anti-Heat Stroke Medicine Market
• 8.8 United Kingdom Anti-Heat Stroke Medicine Market

9. APAC Anti-Heat Stroke Medicine Market

• 9.1 Overview
• 9.2 APAC Anti-Heat Stroke Medicine Market by type
• 9.3 APAC Anti-Heat Stroke Medicine Market by application
• 9.4 Japanese Anti-Heat Stroke Medicine Market
• 9.5 Indian Anti-Heat Stroke Medicine Market
• 9.6 Chinese Anti-Heat Stroke Medicine Market
• 9.7 South Korean Anti-Heat Stroke Medicine Market
• 9.8 Indonesian Anti-Heat Stroke Medicine Market

10. ROW Anti-Heat Stroke Medicine Market

• 10.1 Overview
• 10.2 ROW Anti-Heat Stroke Medicine Market by type
• 10.3 ROW Anti-Heat Stroke Medicine Market by application
• 10.4 Middle Eastern Anti-Heat Stroke Medicine Market
• 10.5 South American Anti-Heat Stroke Medicine Market
• 10.6 African Anti-Heat Stroke Medicine Market

11. Competitor Analysis

• 11.1 Product Portfolio Analysis
• 11.2 Operational Integration
• 11.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

• 12.1 Value Chain Analysis
• 12.2 Growth Opportunity Analysis
  • 12.2.1 Growth Opportunities by Type
  • 12.2.2 Growth Opportunities by Application
• 12.3 Emerging Trends in the Global Anti-Heat Stroke Medicine Market
• 12.4 Strategic Analysis
  • 12.4.1 New Product Development
  • 12.4.2 Certification and Licensing
  • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

• 13.1 Competitive Analysis
• 13.2 Pfizer
  • Company Overview
  • Anti-Heat Stroke Medicine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.3 GlaxoSmithKline
  • Company Overview
  • Anti-Heat Stroke Medicine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.4 Novartis AG
  • Company Overview
  • Anti-Heat Stroke Medicine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.5 Sanofi S.A.
  • Company Overview
  • Anti-Heat Stroke Medicine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.6 Johnson & Johnson
  • Company Overview
  • Anti-Heat Stroke Medicine Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

14. Appendix

• 14.1 List of Figures
• 14.2 List of Tables
• 14.3 Research Methodology
• 14.4 Disclaimer
• 14.5 Copyright
• 14.6 Abbreviations and Technical Units
• 14.7 About Us
• 14.8 Contact Us